 <h1>Bexxar Dosimetric Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tositumomab</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tositumomab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Bexxar Dosimetric.</p><p><i>Applies to tositumomab: intravenous kit</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, vasodilation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash, pruritus</p><p><b>Common</b> (1% to 10%): Sweating<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain, nausea, vomiting, diarrhea, anorexia</p><p><b>Common</b> (1% to 10%): Constipation, dyspepsia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia, thrombocytopenia, anemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic (hypersensitivity) reactions (allergic reaction, facial edema, injection site hypersensitivity, anaphylactic reaction, laryngismus, serum sickness)</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions including fatal anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Positive serology for human anti-mouse antibodies (HAMA)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Infusion reactions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Peripheral edema, weight loss<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia, arthralgia</p><p><b>Common</b> (1% to 10%): Back pain, neck pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, somnolence</p><p><b>Postmarketing reports</b>: Axonal neuropathy leading to quadriparesis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Secondary malignancies (non-melanoma skin, colorectal, head and neck, breast, lung, bladder, melanoma, gastric)</p><p><b>Frequency not reported</b>: Secondary leukemia, myelodysplastic syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia, fever, infections, pain, chills, headache</p><p><b>Common</b> (1% to 10%): Chest pain, serious infections (pneumonia, bacteremia, septicemia, bronchitis, skin infections)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough, pharyngitis, dyspnea, rhinitis</p><p><b>Common</b> (1% to 10%): Pneumonia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. "Product Information. BexxarTherapy (tositumomab)." GlaxoSmithKline Inc, Oakville, IA. </p><h2>More about Bexxar Dosimetric (tositumomab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: CD20 monoclonal antibodies</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diagnosis and Investigation</li>
<li>Non-Hodgkin's Lymphoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>